Business Wire

  1. Henry Schein Medical Announces Private Label-Branded Product, OneStep + Pro Hb Analyzer
    4/24/2019

    Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., announced recently its new private label-branded product, OneStep + Pro Hb Analyzer, a portable, reagent-free hemoglobin analyzer, which measures hemoglobin concentration as a result of a fingerstick blood test

  2. Hologic Receives European CE Mark For ThinPrep Genesis Processor, An Automated Cytology Slide And Molecular Sample System
    4/18/2019

    Hologic, Inc. announced today that the ThinPrep Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in Europe

  3. LabCorp And Envigo Sign Innovative Agreement To Expand Covance’s Nonclinical Drug Development Capabilities And Create An Independent Research Models Provider
    4/17/2019

    LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, and Envigo, a leading provider of nonclinical contract research services and research models, recently announced that LabCorp’s Covance Drug Development segment will acquire Envigo’s nonclinical research services business and Envigo’s Research Models Services business will acquire the Covance Research Products business.

  4. UC Davis Health Images First U.S. Patient Using Ultra-High Resolution CT With Canon Medical’s Aquilion Precision
    4/15/2019

    University of California, Davis (UC Davis) Health is the first institution in the U.S. to use Ultra-High Resolution CT (UHR CT) for clinical imaging, thanks to the installation of the Aquilion Precision from Canon Medical Systems USA, Inc

  5. American Oncology Partners, PA (AOP) Provides Central And Pathology Labs To Enhance Patient Services
    4/5/2019

    Established in 2017, American Oncology Partners, PA (AOP), under the management of the American Oncology Network, LLC (AON), is an alliance of physicians and seasoned health care leaders that provides a unique array of support services to its affiliated community-based oncology practices

  6. Banyan Provides Non-Exclusive License Of Traumatic Brain Injury (TBI) Biomarkers To Abbott For Use On Its Core Laboratory Instruments
    4/4/2019

    Banyan announced today that it will provide Abbott, a global healthcare leader, a license for its traumatic brain injury (TBI) blood biomarkers – Ubiquitin Carboxy-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) – for use on Abbott's core laboratory instruments

  7. Loop Medical Receives Up To USD 3.2 Million To Finalize The Development And Validation Of A Breakthrough Painless And Easy-To-Use Blood Collection Device
    4/4/2019

    Loop Medical recently announced that it has received a $3.2M grant to support pre-production and clinical trials required for the global registration of their medical blood collection device

  8. ATLATL Announces 2019 International Laboratory Ventilation Equipment Open
    4/3/2019

    The Zhangjiang Life and Health Industry (Incubator) Alliance (“Alliance”) has announced that it would host the “2019 Shanghai International Laboratory Ventilation Equipment Open” between July to September this year at the ATLATL Innovation Cluster, located at the heart of Zhangjiang High-Tech Park

  9. The European Molecular Biology Laboratory Selects HID Global’s Industry-Leading RFID Technology In New Design Standard For Cryogenic Research Equipment
    3/27/2019

    HID Global, a worldwide leader in trusted identity solutions, recently announced that the European Molecular Biology Laboratory (EMBL) in Grenoble, France has selected HID’s radio frequency identification (RFID) tags and its patented direct bonding technology for automated handling of biological samples at cryogenic temperatures of 196°C (-321° F) in liquid nitrogen

  10. Center For Gene And Cell Therapy Co-Founded By Miltenyi And ATLATL In Shanghai
    3/20/2019

    To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center for Gene and Cell Therapy